• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S-腺苷甲硫氨酸对动物和人类认知的影响:随机对照试验的系统评价和荟萃分析。

Effects of S-Adenosylmethionine on Cognition in Animals and Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

机构信息

Department of Anatomy, Hebei Medical University, Shijiazhuang, China.

Neuroscience Research Center, Hebei Medical University, Shijiazhuang, China.

出版信息

J Alzheimers Dis. 2023;94(s1):S267-S287. doi: 10.3233/JAD-221076.

DOI:10.3233/JAD-221076
PMID:36970898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10473070/
Abstract

BACKGROUND

There is increasing evidence that supplementation of S-adenosylmethionine (SAM) can improve cognitive function in animals and humans, although the outcomes are not always inconsistent.

OBJECTIVE

We conducted a systematic review and meta-analysis to evaluate the correlation between SAM supplementation and improved cognitive function.

METHODS

We searched studies in the PubMed, Cochrane Library, Embase, Web of Science, and Clinical Trials databases from January 1, 2002 to January 1, 2022. Risk of bias was assessed using the Cochrane risk of bias 2.0 (human studies) and the Systematic Review Center for Laboratory Animal Experimentation risk of bias (animal studies) tools; and evidence quality was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation. STATA software was employed to perform meta-analysis, and the random-effects models was used to evaluate the standardized mean difference with 95% confidence intervals.

RESULTS

Out of the 2,375 studies screened, 30 studies met the inclusion criteria. Meta-analyses of animal (p = 0.213) and human (p = 0.047) studies showed that there were no significant differences between the SAM supplementation and control groups. The results of the subgroup analyses showed that the animals aged ≤8 weeks (p = 0.027) and the intervention duration >8 weeks (p = 0.009) were significantly different compared to the controls. Additionally, the Morris water maze test (p = 0.005) used to assess the cognitive level of the animals revealed that SAM could enhance spatial learning and memory in animals.

CONCLUSION

SAM supplementation showed no significant improvement in cognition. Therefore, further studies are needed to assess the effectiveness of SAM supplementation.

摘要

背景

越来越多的证据表明,补充 S-腺苷甲硫氨酸(SAM)可以改善动物和人类的认知功能,但结果并不总是一致的。

目的

我们进行了一项系统评价和荟萃分析,以评估 SAM 补充与认知功能改善之间的相关性。

方法

我们检索了 2002 年 1 月 1 日至 2022 年 1 月 1 日期间 PubMed、Cochrane 图书馆、Embase、Web of Science 和临床试验数据库中的研究。使用 Cochrane 偏倚风险 2.0(人类研究)和系统评价中心实验室动物实验偏倚风险(动物研究)工具评估偏倚风险;使用推荐评估、制定和评估分级评估证据质量。使用 STATA 软件进行荟萃分析,使用随机效应模型评估标准化均数差值及其 95%置信区间。

结果

在筛选出的 2375 项研究中,有 30 项符合纳入标准。对动物(p=0.213)和人类(p=0.047)研究的荟萃分析显示,SAM 补充组与对照组之间没有显著差异。亚组分析结果表明,≤8 周龄的动物(p=0.027)和干预持续时间>8 周的动物(p=0.009)与对照组相比差异有统计学意义。此外,用于评估动物认知水平的 Morris 水迷宫测试(p=0.005)表明,SAM 可以增强动物的空间学习和记忆能力。

结论

SAM 补充对认知功能没有显著改善。因此,需要进一步研究来评估 SAM 补充的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/311dfb7b2bd1/jad-94-jad221076-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/af21b24a67de/jad-94-jad221076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/bc9df48813f8/jad-94-jad221076-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/c36120ff1674/jad-94-jad221076-g002b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e17087ad54ff/jad-94-jad221076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/2815fe24d2e1/jad-94-jad221076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/f03a03aa73a3/jad-94-jad221076-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/905ff61b1903/jad-94-jad221076-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/f44d3c4c89d7/jad-94-jad221076-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/95b710043d56/jad-94-jad221076-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e3fad8444425/jad-94-jad221076-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/136b2569968c/jad-94-jad221076-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/3b57dc088c4e/jad-94-jad221076-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/2197794cad19/jad-94-jad221076-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/acad0b729499/jad-94-jad221076-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e0548232868a/jad-94-jad221076-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/311dfb7b2bd1/jad-94-jad221076-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/af21b24a67de/jad-94-jad221076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/bc9df48813f8/jad-94-jad221076-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/c36120ff1674/jad-94-jad221076-g002b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e17087ad54ff/jad-94-jad221076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/2815fe24d2e1/jad-94-jad221076-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/f03a03aa73a3/jad-94-jad221076-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/905ff61b1903/jad-94-jad221076-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/f44d3c4c89d7/jad-94-jad221076-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/95b710043d56/jad-94-jad221076-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e3fad8444425/jad-94-jad221076-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/136b2569968c/jad-94-jad221076-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/3b57dc088c4e/jad-94-jad221076-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/2197794cad19/jad-94-jad221076-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/acad0b729499/jad-94-jad221076-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/e0548232868a/jad-94-jad221076-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff67/10473070/311dfb7b2bd1/jad-94-jad221076-g015.jpg

相似文献

1
Effects of S-Adenosylmethionine on Cognition in Animals and Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.S-腺苷甲硫氨酸对动物和人类认知的影响:随机对照试验的系统评价和荟萃分析。
J Alzheimers Dis. 2023;94(s1):S267-S287. doi: 10.3233/JAD-221076.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The effect of S-adenosylmethionine on cognitive performance in mice: an animal model meta-analysis.S-腺苷甲硫氨酸对小鼠认知能力的影响:一项动物模型的荟萃分析。
PLoS One. 2014 Oct 27;9(10):e107756. doi: 10.1371/journal.pone.0107756. eCollection 2014.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review.多不饱和脂肪酸和S-腺苷甲硫氨酸补充剂在痴呆前期综合征和阿尔茨海默病中的应用:综述
ScientificWorldJournal. 2009 May 22;9:373-89. doi: 10.1100/tsw.2009.48.
6
[Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis].[腺苷蛋氨酸与奥沙普秦治疗骨关节炎疗效的Meta分析]
Orthopade. 2002 Nov;31(11):1058-65. doi: 10.1007/s00132-002-0366-1.
7
Physical Activity and Cognition in Sedentary Older Adults: A Systematic Review and Meta-Analysis.体力活动与久坐老年人认知能力的关系:系统评价和荟萃分析。
J Alzheimers Dis. 2022;87(3):957-968. doi: 10.3233/JAD-220073.
8
Animal-assisted therapy for dementia.针对痴呆症的动物辅助疗法。
Cochrane Database Syst Rev. 2019 Nov 25;2019(11):CD013243. doi: 10.1002/14651858.CD013243.pub2.
9
Whether cognitive behavioral therapy is effective for Alzheimer's disease: A protocol for systematic review and network meta-analysis.认知行为疗法是否对阿尔茨海默病有效:系统评价和网络荟萃分析方案。
Medicine (Baltimore). 2021 Jan 8;100(1):e23945. doi: 10.1097/MD.0000000000023945.
10
Ready-to-use therapeutic food (RUTF) for home-based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age.用于6个月至5岁儿童重度急性营养不良家庭营养康复的即食治疗性食品(RUTF)。
Cochrane Database Syst Rev. 2019 May 15;5(5):CD009000. doi: 10.1002/14651858.CD009000.pub3.

引用本文的文献

1
Integrated metabolomic-lipidomic profiling reveals novel biomarkers and therapeutic targets for alcohol use disorder with cognitive impairment.整合代谢组学-脂质组学分析揭示了酒精使用障碍伴认知障碍的新型生物标志物和治疗靶点。
Front Psychiatry. 2025 Jun 13;16:1594313. doi: 10.3389/fpsyt.2025.1594313. eCollection 2025.
2
Introduction to The Special Issue: Novel Molecular Pathways and Therapeutic Challenges in Neurodegenerative Diseases.特刊引言:神经退行性疾病中的新型分子途径与治疗挑战
J Alzheimers Dis. 2023;94(s1):S3-S7. doi: 10.3233/JAD-230622.

本文引用的文献

1
Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia.营养、身体活动和其他生活方式因素在预防认知能力下降和痴呆中的作用。
Nutrients. 2021 Nov 15;13(11):4080. doi: 10.3390/nu13114080.
2
Pharmacokinetic properties of a novel formulation of S-adenosyl-L-methionine phytate.新型 S-腺苷-L-蛋氨酸植酸盐制剂的药代动力学特性。
Amino Acids. 2021 Oct;53(10):1559-1568. doi: 10.1007/s00726-021-03076-7. Epub 2021 Sep 18.
3
Formaldehyde and De/Methylation in Age-Related Cognitive Impairment.
甲醛与年龄相关性认知障碍中的去甲基化/甲基化作用
Genes (Basel). 2021 Jun 13;12(6):913. doi: 10.3390/genes12060913.
4
Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment.阿尔茨海默病动物模型:生物标志物的阐明和认知障碍的治疗方法。
Int J Mol Sci. 2021 May 24;22(11):5549. doi: 10.3390/ijms22115549.
5
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
J Clin Epidemiol. 2021 Jun;134:178-189. doi: 10.1016/j.jclinepi.2021.03.001. Epub 2021 Mar 29.
6
S-Adenosylmethionine Rescues Cognitive Deficits in the rTg4510 Animal Model by Stabilizing Protein Phosphatase 2A and Reducing Phosphorylated Tau.S-腺苷甲硫氨酸通过稳定蛋白磷酸酶 2A 和减少磷酸化 tau 来挽救 rTg4510 动物模型中的认知缺陷。
J Alzheimers Dis. 2020;77(4):1705-1715. doi: 10.3233/JAD-200756.
7
[Epidemiology of Alzheimer's disease: latest trends].[阿尔茨海默病流行病学:最新趋势]
Rev Prat. 2020 Feb;70(2):149-151.
8
S-Adenosylmethionine Alleviates Amyloid-β-Induced Neural Injury by Enhancing Trans-Sulfuration Pathway Activity in Astrocytes.S-腺苷甲硫氨酸通过增强星形胶质细胞中的转硫途径活性减轻β-淀粉样蛋白诱导的神经损伤。
J Alzheimers Dis. 2020;76(3):981-995. doi: 10.3233/JAD-200103.
9
Abnormality of m6A mRNA Methylation Is Involved in Alzheimer's Disease.m6A mRNA甲基化异常与阿尔茨海默病有关。
Front Neurosci. 2020 Feb 28;14:98. doi: 10.3389/fnins.2020.00098. eCollection 2020.
10
Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project.轻度认知障碍和主观认知衰退中的特定营养生物标志物谱与临床进展相关:NUDAD项目
J Am Med Dir Assoc. 2020 Oct;21(10):1513.e1-1513.e17. doi: 10.1016/j.jamda.2019.12.009. Epub 2020 Jan 27.